Table 2.
Assay performance simulating high-volume CT/NG testing (n = 555*), results for Chlamydia trachomatis†
| Aptima Combo 2 | ||||
|---|---|---|---|---|
| CT positive | CT negative | Total | ||
| cobas CT/NG | CT positive | 31 | 1 | 32 |
| CT negative | 0 | 523 | 523 | |
| Total | 31 | 524 | 555 | |
| PPA (95% CI), NPA (95% CI) | 100 (88.8, 100) | 99.8 (98.9, 100) | ||
| OPA (95% CI) | 99.8 (99, 100) | |||
| p-value‡ | 1 | |||
*One CT specimen was not included in the CT method correlation because of an equivocal result generated by the Aptima Combo 2 assay (cobas CT/NG: “CT Positive” and Aptima Combo 2: “CT UNBEST”)
†Comparison of cobas CT/NG for use on the cobas 6800 system and Aptima Combo 2 on the Panther system
‡Calculated using McNemar’s test
Abbreviations: CI confidence interval, CT Chlamydia trachomatis, NPA negative percent agreement, OPA overall percent agreement, PPA positive percent agreement